Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings

被引:0
|
作者
Stephanie A. Hooker [1 ]
Colleen Starkey [1 ]
Gavin Bart [2 ]
Rebecca C. Rossom [1 ]
Sheryl Kane [1 ]
Anthony W. Olson [3 ]
机构
[1] HealthPartners Institute,
[2] Research and Evaluation Division,undefined
[3] Hennepin Healthcare,undefined
[4] Essentia Institute of Rural Health,undefined
来源
BMC Primary Care | / 25卷 / 1期
关键词
Substance-related disorders; Adherence; Medications for opioid Use Disorder; Outpatient treatment;
D O I
10.1186/s12875-024-02609-9
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] EVALUATION OF A MULTIDISCIPLINARY PRIMARY CARE-BASED TRANSITION CLINIC FOR PATIENTS NEWLY INITIATING BUPRENORPHINE FOR OPIOID USE DISORDER
    Sehgal, Sonia
    Stolebarger, Laura
    Hansen, Annika M.
    Lanier, Nicola E.
    Garcia, Luke M.
    Incze, Michael A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S661 - S661
  • [42] Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder
    Chang, Hsien-Yen
    Daubresse, Matthew
    Saloner, Brendan
    Alexander, G. Caleb
    MEDICAL CARE, 2019, 57 (09) : 667 - 672
  • [43] Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
    Frost, Madeline C.
    Soyer, Elena M.
    Achtmeyer, Carol E.
    Hawkins, Eric J.
    Glass, Joseph E.
    Hallgren, Kevin A.
    Williams, Emily C.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [44] Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
    Madeline C. Frost
    Elena M. Soyer
    Carol E. Achtmeyer
    Eric J. Hawkins
    Joseph E. Glass
    Kevin A. Hallgren
    Emily C. Williams
    Addiction Science & Clinical Practice, 18
  • [45] Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings
    Peterson, Lauren
    Murugesan, Manoradhan
    Nocon, Robert
    Hoang, Hank
    Bolton, Joshua
    Laiteerapong, Neda
    Pollack, Harold
    Marsh, Jeanne
    PLOS ONE, 2022, 17 (10):
  • [46] A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective
    Kinsky, Suzanne
    Houck, Patricia R.
    Mayes, Kristin
    Loveland, David
    Daley, Dennis
    Schuster, James M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 104 : 15 - 21
  • [47] Buprenorphine implant in opioid use disorder
    Martins, B.
    Agostinho, C.
    Aleixo, A.
    Martins, M.
    EUROPEAN PSYCHIATRY, 2018, 48 : S334 - S335
  • [48] Buprenorphine Therapy for Opioid Use Disorder
    Zoorob, Roger
    Kowalchuk, Alicia
    de Grubb, Maria Mejia
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (05) : 313 - 320
  • [49] Use of Buprenorphine to Treat Opioid Use Disorder
    Bartholow, Lydia Anne M.
    Pope, Justine
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (11) : 9 - 12
  • [50] Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
    Ellis, Matthew S.
    Xu, Kevin Y.
    Tardelli, Vitor S.
    Fidalgo, Thiago M.
    Buttram, Mance E.
    Grucza, Richard A.
    JAMA PSYCHIATRY, 2023, 80 (12) : 1269 - 1276